Apollo Hospitals Enterprise Limited APOLLOHOSP.NS
IN · National Stock Exchange of India · XNSE · stock · Healthcare · website
Apollo Hospitals Enterprise Limited financials (annual)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | ₹252.3B | ₹217.9B | ₹188.6B | ₹164.4B |
| Gross profit | ₹121.5B | ₹104.8B | ₹90.6B | ₹78.7B |
| SG&A expense | — | ₹26.9B | ₹25.5B | ₹21.3B |
| Operating income | ₹28.9B | ₹22.6B | ₹17.1B | ₹14.5B |
| Interest expense | ₹4.5B | ₹4.6B | ₹4.1B | ₹3.1B |
| Income tax | ₹6.6B | ₹5.3B | ₹4.5B | ₹2.6B |
| Net income | ₹19.4B | ₹14.5B | ₹9.0B | ₹8.2B |
| EPS (diluted) | ₹135.04 | ₹100.56 | ₹62.50 | ₹56.97 |
| Operating cash flow | ₹28.6B | ₹21.4B | ₹19.2B | ₹13.8B |
| Free cash flow | ₹8.9B | ₹4.2B | ₹7.8B | ₹2.5B |
| Cash & equivalents | ₹8.1B | ₹5.8B | ₹5.1B | ₹4.3B |
| Inventory | ₹5.4B | ₹4.8B | ₹4.6B | ₹3.9B |
| Total assets | ₹222.0B | ₹206.6B | ₹167.5B | ₹144.3B |
| Total liabilities | ₹122.2B | ₹120.0B | ₹94.3B | ₹79.0B |
| Shareholders' equity | ₹94.8B | ₹82.1B | ₹69.4B | ₹62.0B |
Growth · year-over-year · Revenue CAGR 15.3%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +15.8% | +15.5% | +14.7% | — |
| Net income growth | +34.3% | +60.9% | +9.7% | — |
| EPS growth | +34.3% | +60.9% | +9.7% | — |
| Free cash flow growth | +110.9% | -45.9% | +215.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · IN · as of 2026-03-31. Figures in INR. Facts plus Stocktoria's own computed scores — not investment advice.